ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

WGS GeneDx Holdings Corporation

92.245
-2.22 (-2.34%)
Last Updated: 18:07:25
Delayed by 15 minutes

GeneDx Financial Summary

The current WGS market cap is 2.59B. The company's latest EPS is USD -1.8628 and P/E is -49.74.

Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 57.42M62.42M70.51M76.87M95.64M
Operating Income -37.72M-13.66M-10.58M-7.78M7.31M
Net Income -24.74M-20.24M-29.17M-8.31M5.44M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0212.2M234.69M202.57M305.45M
Operating Income -206k-446.15M-457.51M-182.27M-23.21M
Net Income -192k-245.39M-548.98M-175.77M-52.29M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 418.76M394.53M389.1M408.84M419.38M
Total Liabilities 190.74M187.31M195.06M204.34M174.13M
Total Equity 228.02M207.22M194.04M204.5M245.25M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 444.14M554.09M490.94M418.76M419.38M
Total Liabilities 15.59M165.99M237.24M190.74M174.13M
Total Equity 5M388.1M253.71M228.02M245.25M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -180.15M-16.41M-20.92M-25.31M-28.5M
Investing -43.73M843k-21.86M-29.61M-30.13M
Financing 186.24M-438k-829k13.14M44.16M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -386k-190.43M-319.16M-180.15M-28.5M
Investing -442.75M-20.79M-141.33M-43.73M-30.13M
Financing 444.23M493.73M197.32M186.24M44.16M
Market Cap 2.59B
Price to Earnings Ratio -49.74
Price to Sales Ratio 8.51
Price to Cash Ratio 30.52
Price to Book Ratio 10.6
Dividend Yield -

Share Statistics

Shares Outstanding 28.07M
Average Volume (1 week) 750.19k
Average Volume (1 Month) 1.16M
52 Week Change 667.43%
52 Week High 115.5999
52 Week Low 7.72
Spread (Intraday) 0.34 (0.37%)

Company Info

Company Name GeneDx Holdings Corporation
Address 1209 orange street
wilmington, delaware 19801
Website https://www.genedx.com
Industry health services (8000)